Planet Labs Stock Has Quickly Fallen 40%. Time to Buy the Dip?

Planet Labs fell more than 40% in the past month, from about $51 to around $28, as investors rotated capital toward SpaceX and the stock came under pressure despite solid Q1 fiscal 2027 results. Revenue rose 42% year over year to $94.2 million and backlog increased 72% to $906 million, but the company posted a $138.9 million net loss, including a $106.5 million noncash warrant liability adjustment. Planet ended the quarter with $730.8 million in cash and saw Defense and Intelligence revenue grow more than 65%, but it still appears several years from consistent profitability and trades at a 26.9 price-to-sales ratio.

Analysis

The move looks less like a fundamental reset and more like a factor-driven de-rating caused by private-markets crowding. Capital rotating toward SpaceX likely pulled the “scarcity premium” out of public-space names first, which matters because these stocks trade more on narrative liquidity than near-term earnings power. That creates a reflexive setup: once momentum breaks, quant and retail holders de-risk together, and the multiple compresses faster than the business fundamentals change.

The real issue is not revenue quality but duration risk. Planet is still in the heavy-investment phase, so every quarter of strong bookings can still be overwhelmed by a single valuation-sensitive accounting swing or a small miss in cash burn, especially when the stock is priced for a much steeper path to margin expansion. In that regime, the market will tolerate losses only if backlog converts cleanly into operating leverage; any slippage in satellite deployment cadence or customer concentration could keep the multiple under pressure for months.

Second-order, defense demand is a legitimate floor, but it may not be enough to justify the current valuation relative to public comps. If procurement remains robust, the better trade may be to own the business model with lower expectations embedded, rather than the name with the richer multiple and more crowded ownership. The overhang from SpaceX also means any further private-market headlines can keep a lid on PL even if execution stays strong.

The contrarian read is that this is a sentiment washout, not a thesis break, and that creates a tradable asymmetry. The downside from here is likely slower and more valuation-dependent, while the upside requires only a re-rating back toward the prior range once the flow bid reverses or the next quarter confirms operating leverage. That makes timing more important than conviction: the stock can still work, but only if you are paid for 6-12 months of patience.

Key Decisions for Investors

• Avoid chasing PL here; wait for either a post-earnings consolidation or a further 10-15% flush before considering a long entry, because the near-term risk remains multiple compression rather than fundamental deterioration.
• If already long PL, reduce size and hedge with a short BKSY basket or an index hedge over the next 1-3 months; PL carries the richer valuation and therefore the highest sensitivity to any additional risk-off in space names.
• For a relative-value expression, pair long BKSY / short PL on a 3-6 month horizon: BKSY offers a cheaper public-defense-data proxy if the sector stays bid, while PL remains more exposed to de-rating from private-market competition.
• Use PL Jan-2027 put spreads as a tactical hedge or bearish expression if you expect the market to keep punishing duration assets; this limits premium outlay while capturing further downside if profitability keeps moving out in time.
• Monitor any SpaceX IPO/private-market headlines and next-quarter backlog conversion; a stabilization in public space flows plus another strong defense contract print would be the clearest catalyst to cover shorts or re-enter long PL.